Insights into the genetic and molecular basis of primary pulmonary hypertension

Pediatric Research

Volumn 53, Issue 6, 2003, Pages 883-888

  Trembath, Richard C ^a   Harrison, Rachel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BMPR2 GENE; CHILD; CHROMOSOME 2; DISEASE CLASSIFICATION; FEMALE; GENE; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; LUNG ARTERY PRESSURE; MALE; MULTIGENE FAMILY; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING TEST;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; GENETIC SCREENING; HUMANS; HYPERTENSION, PULMONARY; MUTATION; PROTEIN-SERINE-THREONINE KINASES; TELANGIECTASIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037941375     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000061565.22500.E7     Document Type: Review

References (37)

1. Tuder RM, Lee SD, Cool CC 1998 Histopathology of pulmonary hypertension. Chest 114:1S-6S
2. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK 1987 Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216-223
3. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT 1991 Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343-349
4. Oakley CW 1994 Primary pulmonary hypertension: case series from the UK. Chest 105(suppl):S29-32
5. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B 1996 Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group N Engl J Med 335:609-616
6. British Cardiac Society G, Medical Practice C, approved by the British Thoracic S, the British Society of R 2001 Recommendations on the management of pulmonary hypertension in clinical practice. Heart 86:11-13
7. Haworth SG 1998 Primary pulmonary hypertension in childhood. Arch Dis Child 79:452-455
8. Gomez-Sanchez MA, Saenz de la Calzada C, Gomez-Pajuelo C, Martinez-Tello FJ, Mestre de Juan MJ, James TN 1991 Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome. J Am Coll Cardiol 18:1539-1545
9. Loyd JE, Primm RK, Newman JH 1984 Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 129:194-197
10. Rich S Executive summary 1998 Genetics of pulmonary hypertension. World symposium on primary pulmonary hypertension, Evian, France
11. Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, Newman JH 1995 Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 152:93-97
12. Nichols WC, Koller DL, Slovis B, Foroud T, Terry VH, Arnold ND, Siemieniak DR, Wheeler L, Phillips JA, Newman JH, Conneally PM, Ginsburg D, Loyd JE 1997 Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 15:277-280
13. Morse JH, Jones AC, Barst RJ, Hodge SE, Wilhelmsen KC, Nygaard TG 1997 Mapping of familial primary pulmonary hypertension locus (PPHI) to chromosome 2q31-q32. Circulation 95:2603-2606
14. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA 2000 Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737-744
15. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA, 3rd, Newman J, Williams D, Galie N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC 2001 BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension Am J Hum Genet 68:92-102
16. Machado RD, Pauciulo MW, Fretwell N, Veal C, Thomson JR, Vilarino Guell C, Aldred M, Brannon CA, Trembath RC, Nichols WC 2000 A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. International PPH Consortium Genomics 68:220-228
17. Deng Z, Haghighi F, Helleby L, Vanterpool K, Horn EM, Barst RJ, Hodge SE. Morse JH, Knowles JA 2000 Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. Am J Respir Crit Care Med 161:1055-1059
18. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC 2000 Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. International PPH Consortium Nat Genet 26:81-84
19. Massague J, Wotton D 2000 Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19:1745-1754
20. Ducy P, Karsenty G 2000 The family of bone morphogenetic proteins. Kidney Int 57:2207-2214
21. Miyazono K, Kusanagi K, Inoue H 2001 Divergence and convergence of TGF-beta/ BMP signaling. J Cell Physiol 187:265-276
22. Massague J 1998 TGF-beta signal transduction. Ann Rev Biochem 67:753-791
23. Blobe GC, Schiemann WP, Lodish HF 2000 Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358
24. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, Newman J, Wheeler L, Higenbottam T, Gibbs JS, Egan J, Crozier A, Peacock A, Allcock R, Corris P, Loyd JE, Trembath RC, Nichols WC 2000 Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37:741-745
25. Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, Trembath RC 2001 Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 104:790-795
26. Atkinson CWS Upton PD, Shackleton S, Thomson JR, Trembath RC, Morrell NW 2002 Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of BMPR-II. Circulation 105:1672-1678
27. Humbert M, Deng Z, Simonneau G, Barst RJ, Sitbon O, Wolf M, Cuervo N, Moore KJ, Hodge SE, Knowles JA, Morse JH 2002 BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 20:518-523
28. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S 2001 Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150
29. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM 1998 Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101:927-934
30. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM 2001 Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88:E2-E11
31. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J 1994 Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351
32. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA 1996 Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195
33. Sapru RP HD, Hall JI 1969 Pulmonary hypertension in patients with pulmonary arteriovenous fistulae. Br Heart J 31:559-569
34. Trell EJB, Linell F, Pipa J 1972 Familial pulmonary hypertension and multiple abnormalities of large systemic arteries in Osler's disease. Am J Med 53:50-63
35. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L 2001 Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325-334
36. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA 1998 Overexpression of transforming growth factor beta 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 95:6983-6988
37. Grunig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C, Olschewski H, Kuecherer HF, Kubler W 2000 Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 102:1145-1150